乳酸细菌-肠道-微生物群-对炎症性肠道疾病进行介导干预
Diantong Li1,2, Zhenjiang Liu1,3, Xueni Fan1,2
1Institute of Animal Husbandry and Veterinary, Xizang Academy of Agricultural and Animal Husbandry Sciences, Key Laboratory of Animal Genetics and Breeding on Tibetan Plateau, Ministry of Agriculture and Rural Affairs, Lhasa 850000, China.
Microorganisms
|September 28, 2024
概括
乳酸细菌 (LAB) 通过改善肠道健康和减少炎症,在治疗炎症性肠病 (IBD) 中表现有前途. 然而,它们的有效性在性结肠炎 (UC) 和克罗恩病 (CD) 之间有所不同,因此需要进一步研究以优化应用.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),具有复杂的致病性,涉及遗传,环境和制药因素.
- 乳酸细菌 (LAB) 越来越多地用于IBD管理,因为它们对肠道屏障功能,炎症和肠道微生物群调节的有益作用.
研究的目的:
- 阐明IBD的发病机制,并探索UC和CD中LAB治疗的机制.
- 研究LAB对肠道屏障功能的影响,肠道微生物群的稳定性和炎症途径.
- 确定LAB在IBD治疗中的局限性,并为优化治疗应用提供见解.
主要方法:
- 审查有关IBD病原和LAB机制的现有文献.
- 分析LAB对肠道屏障完整性和肠道微生物群组成的影响.
- 研究肠道微生物群,代谢物和IBD炎症途径之间的相互作用.
主要成果:
- LAB可以增强肠道屏障功能和调节肠道微生物群,可能减轻IBD相关的炎症.
- 在UC和CD之间,LAB治疗的疗效和机制不同.
- 在IBD中,肠道微生物群,代谢物和炎症途径之间存在复杂的相互作用.
结论:
- LAB对IBD具有治疗潜力,但它们的应用需要仔细考虑疾病特异性的变异.
- 需要进一步的研究来优化基于LAB的策略来管理UC和CD.
- 了解复杂的肠道微生物群与宿主相互作用对于推进IBD治疗至关重要.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
01:29Bacterial Flora of the Large Intestine
394
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
394
01:21Inflammatory Bowel Disease V: Surgical Management
128
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
128
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:21Drugs for Treatment of Constipation-Predominant IBS
140
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140
01:17Irritable Bowel Syndrome I: Introduction
254
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
254